Novo Nordisk’s Wegovy head start on pills forces investors to rethink Eli Lilly’s GLP-1 dominance5. Mai 2026
News Wandercraft Raises $75M for Self-Balancing ExoskeletonsHealthradar15. Juni 2025 What You Should Know: – Wandercraft, the global leader in self-balancing robotic mobility systems secures $75M in funding and financing…
